Apac Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.25 M
as on 15-11-2024
- Paid Up Capital ₹ 3.60 M
as on 15-11-2024
- Company Age 14 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.80 M
as on 15-11-2024
- Revenue 20.87%
(FY 2023)
- Profit -94.76%
(FY 2023)
- Ebitda 22.84%
(FY 2023)
- Net Worth -40.17%
(FY 2023)
- Total Assets -41.17%
(FY 2023)
About Apac Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.25 M and a paid-up capital of Rs 3.60 M.
The company currently has active open charges totaling ₹1.80 M.
Arun Mehra, Anita Mehra, Sanjiv Jain, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110DL2010PTC211616
- Company No.
211616
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Apac Biotech Private Limited offer?
Apac Biotech Private Limited offers a wide range of products and services, including Medical Treatment Services, Cancer Treatment, Medical Surgery & Treatment Centres.
Who are the key members and board of directors at Apac Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Mehra  | Managing Director | 21-Dec-2010 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anita Mehra | Director | 11-Jan-2011 | Current |
| Sanjiv Jain | Director | 21-Dec-2010 | Current |
| Bandana Sharan | Director | 01-Apr-2011 | Current |
| Atika Mehra | Additional Director | 19-Feb-2024 | Current |
| Anju Jain | Director | 24-Jan-2011 | Current |
Financial Performance of Apac Biotech.
Apac Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.87% increase. The company also saw a substantial fall in profitability, with a 94.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apac Biotech?
In 2023, Apac Biotech had a promoter holding of 96.20% and a public holding of 3.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Denvax Cellular Therapies Private LimitedActive 15 years 4 monthsArun Mehra, Anita Mehra and 2 more are mutual person
Apac Spclty Labs Private LimitedActive 10 years 10 daysAnita Mehra, Bandana Sharan and 1 more are mutual person
- Advantage Integrated Advisory Services Private LimitedActive 16 years 6 months
Atika Mehra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Jul 2023 | ₹0.30 M | Open |
Hdfc Bank Limited Creation Date: 29 Sep 2022 | ₹1.49 M | Open |
How Many Employees Work at Apac Biotech?
Unlock and access historical data on people associated with Apac Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apac Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apac Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
